| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achieving end-to-end success in the clinic: Pfizer’s learnings on R&D productivity
|
Fernando, Kathy
|
|
|
27 |
3 |
p. 697-704
|
artikel
|
| 2 |
A molecular perspective for the use of type IV tyrosine kinase inhibitors as anticancer therapeutics
|
Das, Rudradip
|
|
|
27 |
3 |
p. 808-821
|
artikel
|
| 3 |
Contents page
|
|
|
|
27 |
3 |
p. i-ii
|
artikel
|
| 4 |
Docking and scoring for nucleic acid–ligand interactions: Principles and current status
|
Feng, Yuyu
|
|
|
27 |
3 |
p. 838-847
|
artikel
|
| 5 |
Drug-induced QT Prolongation Atlas (DIQTA) for enhancing cardiotoxicity management
|
Li, Shihai
|
|
|
27 |
3 |
p. 831-837
|
artikel
|
| 6 |
Emerging role and promise of nanomaterials in organoid research
|
Mahapatra, Chinmaya
|
|
|
27 |
3 |
p. 890-899
|
artikel
|
| 7 |
How doppelgänger effects in biomedical data confound machine learning
|
Wang, Li Rong
|
|
|
27 |
3 |
p. 678-685
|
artikel
|
| 8 |
Metagenomic sequencing-driven multidisciplinary approaches to shed light on the untapped microbial natural products
|
Wu, Changsheng
|
|
|
27 |
3 |
p. 730-742
|
artikel
|
| 9 |
Molecular approaches for the treatment and prevention of Friedreich's ataxia
|
Yang, Wenyao
|
|
|
27 |
3 |
p. 866-880
|
artikel
|
| 10 |
Molecular interactions at the colchicine binding site in tubulin: An X-ray crystallography perspective
|
Wang, Jiaxing
|
|
|
27 |
3 |
p. 759-776
|
artikel
|
| 11 |
Non-invasive cell-tracking methods for adoptive T cell therapies
|
Van Hoeck, Jelter
|
|
|
27 |
3 |
p. 793-807
|
artikel
|
| 12 |
Obesity and insulin resistance: Pathophysiology and treatment
|
Tong, Yue
|
|
|
27 |
3 |
p. 822-830
|
artikel
|
| 13 |
Petite miracles: insight into the nano-management of scarless wound healing
|
Pan, Bei Ho
|
|
|
27 |
3 |
p. 857-865
|
artikel
|
| 14 |
Regulating NETosis: An emerging facet of statin pleiotropy
|
Radbakhsh, Shabnam
|
|
|
27 |
3 |
p. 675-677
|
artikel
|
| 15 |
Regulatory oversight on the use of experimental therapies during a pandemic: The case of early access to convalescent plasma therapy in three LMICs
|
Bernabe, Rosemarie
|
|
|
27 |
3 |
p. 686-689
|
artikel
|
| 16 |
Targeting Ca2+ signaling: A new arsenal against cancer
|
Panda, Suman
|
|
|
27 |
3 |
p. 923-934
|
artikel
|
| 17 |
Targeting T-type channels in cancer: What is on and what is off?
|
Visa, Anna
|
|
|
27 |
3 |
p. 743-758
|
artikel
|
| 18 |
The global hearing therapeutic pipeline: 2021
|
Isherwood, Beverley
|
|
|
27 |
3 |
p. 912-922
|
artikel
|
| 19 |
The overlooked vital sign: The importance of measuring sleep in drug development studies
|
McCarthy, Marie
|
|
|
27 |
3 |
p. 690-696
|
artikel
|
| 20 |
The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19
|
Basile, Maria Sofia
|
|
|
27 |
3 |
p. 848-856
|
artikel
|
| 21 |
Therapeutic potential of curcumin in endometrial disorders: Current status and future perspectives
|
Singh, Apoorva
|
|
|
27 |
3 |
p. 900-911
|
artikel
|
| 22 |
The role of DMPK science in improving pharmaceutical research and development efficiency
|
Mak, Kit-Kay
|
|
|
27 |
3 |
p. 705-729
|
artikel
|
| 23 |
Unlocking the Wnt pathway: Therapeutic potential of selective targeting FZD7 in cancer
|
Larasati, Yonika
|
|
|
27 |
3 |
p. 777-792
|
artikel
|
| 24 |
Using medical microwave radiometry for brain temperature measurements
|
Shevelev, Oleg
|
|
|
27 |
3 |
p. 881-889
|
artikel
|
Tijdschrift beschrijving